Natural killer cells and killer cell immunoglobulin-like receptors in solid organ transplantation: Protectors or opponents? MR Zamir, A Shahi, S Salehi, A Amirzargar Transplantation Reviews 36 (4), 100723, 2022 | 9 | 2022 |
Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders MR Haghshenas, MR Zamir, M Sadeghi, MJ Fattahi, K Mirshekari, ... European cytokine network 33 (3), 54-69, 2022 | 6 | 2022 |
SARS-CoV-2 helicase might interfere with cellular nonsense-mediated RNA decay: insights from a bioinformatics study B Akbari, E Ahmadi, MR Zabihi, MR Zamir, MS Shaker, F Noorbakhsh BMC Genomic Data 24 (1), 68, 2023 | 3 | 2023 |
Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis M Zareinejad, F Mehdipour, M Roshan-Zamir, Z Faghih, A Ghaderi Cancers 15 (19), 4771, 2023 | 2 | 2023 |
Immune Profiling of SARS-CoV-2; What We Know and What We Don’t Know M Zohouri, A Ghods, MR Zamir, F Shokri, A Ghaderi Iranian Journal of Allergy, Asthma and Immunology 22 (3), 217-232, 2023 | 1 | 2023 |
The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer MR Zamir, A Ariafar, A Ghaderi, A Amirzargar Immunobiology 228 (2), 152319, 2023 | 1 | 2023 |
Oral Squamous Cell Carcinoma: Focus on Biomarkers for Screening H Ghaderi, M Roshan-Zamir, M Jafarinia, E Kruger Journal of Dentistry 25 (1), 1, 2024 | | 2024 |